Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VOENA, C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomasCORRADINI, P; BOCCADORO, M; VOENA, C et al.The Journal of experimental medicine. 1993, Vol 178, Num 3, pp 1091-1096, issn 0022-1007Article

High-dose sequential chemoradiotherapy in multiple myeloma : residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autograftingCORRADINI, P; VOENA, C; ASTOLFI, M et al.Blood. 1995, Vol 85, Num 6, pp 1596-1602, issn 0006-4971Article

Idiotype vaccination in human myeloma : Generation of tumor-specific immune responses after high-dose chemotherapyMASSAIA, M; BORRIONE, P; PEOLA, S et al.Blood. 1999, Vol 94, Num 2, pp 673-683, issn 0006-4971Article

Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantationVOENA, C; MALNATI, M; MAJOLINO, I et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 8, pp 791-793, issn 0268-3369, 3 p.Article

Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancerCORRADINI, P; VOENA, C; ASTOLFI, M et al.Annals of oncology. 2001, Vol 12, Num 12, pp 1693-1698, issn 0923-7534Article

Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autograftingCORRADINI, P; ASTOLFI, M; CHERASCO, C et al.Blood. 1997, Vol 89, Num 2, pp 724-731, issn 0006-4971Article

Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphomaCORRADINI, P; LADETTO, M; ASTOLFI, M et al.British journal of haematology. 1996, Vol 94, Num 2, pp 376-378, issn 0007-1048Article

Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasiasCORRADINI, P; INGHIRAMI, G; PILERI, A et al.Leukemia. 1994, Vol 8, Num 5, pp 758-767, issn 0887-6924Article

  • Page / 1